Received Jun 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | called doctor t | IM / LA |
Possible extra dose due to patient may have already completed child / adolescent series
none
n/a
n/a
Latex
n/a